• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与美国双阿司匹林交联血红蛋白(DCLHb)临床疗效试验患者的紧急复苏

Emergency Resuscitation of Patients Enrolled in the US Diaspirin Cross-linked Hemoglobin (DCLHb) Clinical Efficacy Trial.

作者信息

Sloan Edward P, Koenigsberg Max, Weir W Brad, Clark James M, O'Connor Robert, Olinger Michael, Cydulka Rita

机构信息

1Department of Emergency Medicine,University of Illinois at Chicago,Chicago,IllinoisUSA.

2Advocate Illinois Masonic Medical Center,Chicago,IllinoisUSA.

出版信息

Prehosp Disaster Med. 2015 Feb;30(1):54-61. doi: 10.1017/S1049023X14001174. Epub 2014 Dec 15.

DOI:10.1017/S1049023X14001174
PMID:25499006
Abstract

INTRODUCTION

Optimal emergent management of traumatic hemorrhagic shock patients requires a better understanding of treatment provided in the prehospital/Emergency Medical Services (EMS) and emergency department (ED) settings. Hypothesis/Problem Described in this research are the initial clinical status, airway management, fluid and blood infusions, and time course of severely-injured hemorrhagic shock patients in the EMS and ED settings from the diaspirin cross-linked hemoglobin (DCLHb) clinical trial.

METHODS

Data were analyzed from 17 US trauma centers gathered during a randomized, controlled, single-blinded efficacy trial of a hemoglobin solution (DCLHb) as add-on therapy versus standard therapy.

RESULTS

Among the 98 randomized patients, the mean EMS Glasgow Coma Scale (GCS) was 10.6 (SD = 5.0), the mean EMS revised trauma score (RTS) was 6.3 (SD = 1.9), and the mean injury severity score (ISS) was 31 (SD = 17). Upon arrival to the ED, the GCS was 20% lower (7.8 (SD = 5.3) vs 9.7 (SD = 6.3)) and the RTS was 12% lower (5.3 (SD = 2.0) vs 6.0 (SD = 2.1)) than EMS values in blunt trauma patients (P < .001). By ED disposition, 80% of patients (78/98) were intubated. Rapid sequence intubation (RSI) was utilized in 77% (60/78), most often utilizing succinylcholine (65%) and midazolam (50%). The mean crystalloid volume infused was 4.2 L (SD = 3.4 L), 80% of which was infused within the ED. Emergency department blood transfusion occurred in 62% of patients, with an average transfused volume of 1.2 L (SD = 2.0 L). Blunt trauma patients received 2.1 times more total fluids (7.4 L vs 3.5 L, < .001) and 2.4 times more blood (2.4 L vs 1.0 L, P < .001). The mean time of patients taken from injury site to operating room (OR) was 113 minutes (SD = 87 minutes). Twenty-one (30%) of the 70 patients taken to the OR from the ED were sent within 60 minutes of the estimated injury time. Penetrating trauma patients were taken to the OR 52% sooner than blunt trauma patients (72 minutes vs 149 minutes, P < .001).

CONCLUSION

Both GCS and RTS decreased prior to ED arrival in blunt trauma patients. Intubation was performed using RSI, and crystalloid infusion of three times the estimated blood loss volume (L) and blood transfusion of the estimated blood loss volume (L) were provided in the EMS and ED settings. Surgical intervention for these trauma patients most often occurred more than one hour from the time of injury. Penetrating trauma patients received surgical intervention more rapidly than those with a blunt trauma mechanism.

摘要

引言

创伤性失血性休克患者的最佳紧急处理需要更好地了解在院前/紧急医疗服务(EMS)和急诊科(ED)所提供的治疗。本研究中描述的假设/问题是来自双阿司匹林交联血红蛋白(DCLHb)临床试验的严重受伤失血性休克患者在EMS和ED环境中的初始临床状态、气道管理、液体和血液输注以及时间进程。

方法

分析了在美国17个创伤中心收集的数据,这些数据来自一项随机、对照、单盲的血红蛋白溶液(DCLHb)作为附加治疗与标准治疗的疗效试验。

结果

在98例随机分组的患者中,EMS的格拉斯哥昏迷量表(GCS)平均为10.6(标准差=5.0),EMS修订创伤评分(RTS)平均为6.3(标准差=1.9),平均损伤严重程度评分(ISS)为31(标准差=17)。到达急诊科时,钝性创伤患者的GCS比EMS时低20%(7.8(标准差=5.3)对9.7(标准差=6.3)),RTS比EMS时低12%(5.3(标准差=2.0)对6.0(标准差=2.1))(P<.001)。根据急诊科处置情况,80%的患者(78/98)进行了插管。77%(60/78)的患者采用了快速顺序诱导插管(RSI),最常用的是琥珀酰胆碱(65%)和咪达唑仑(50%)。输注的晶体液平均量为4.2L(标准差=3.4L),其中80%在急诊科输注。62%的患者在急诊科接受了输血,平均输血量为1.2L(标准差=2.0L)。钝性创伤患者接受的总液体量多2.1倍(7.4L对3.5L,P<.001),输血量多2.4倍(2.4L对1.0L,P<.001)。患者从受伤部位到手术室(OR)的平均时间为113分钟(标准差=87分钟)。从急诊科送往手术室的70例患者中有21例(30%)在估计受伤时间的60分钟内被送去。穿透性创伤患者比钝性创伤患者早52%被送往手术室(72分钟对149分钟,P<.001)。

结论

钝性创伤患者在到达急诊科之前GCS和RTS均下降。采用RSI进行插管,在EMS和ED环境中输注了估计失血量3倍体积(L)的晶体液和估计失血量(L)的血液。这些创伤患者的手术干预大多在受伤后1小时以上进行。穿透性创伤患者比钝性创伤机制的患者接受手术干预更快。

相似文献

1
Emergency Resuscitation of Patients Enrolled in the US Diaspirin Cross-linked Hemoglobin (DCLHb) Clinical Efficacy Trial.参与美国双阿司匹林交联血红蛋白(DCLHb)临床疗效试验患者的紧急复苏
Prehosp Disaster Med. 2015 Feb;30(1):54-61. doi: 10.1017/S1049023X14001174. Epub 2014 Dec 15.
2
The use of the Revised Trauma Score as an entry criterion in traumatic hemorrhagic shock studies: data from the DCLHb clinical trials.修订创伤评分作为创伤性出血性休克研究的纳入标准的应用:来自 DCLHb 临床试验的数据。
Prehosp Disaster Med. 2012 Aug;27(4):330-44. doi: 10.1017/S1049023X12000970. Epub 2012 Jul 30.
3
Diaspirin cross-linked hemoglobin infusion did not influence base deficit and lactic acid levels in two clinical trials of traumatic hemorrhagic shock patient resuscitation.在两项创伤性失血性休克患者复苏的临床试验中,双阿司匹林交联血红蛋白输注并未影响碱缺失和乳酸水平。
J Trauma. 2010 May;68(5):1158-71. doi: 10.1097/TA.0b013e3181bbfaac.
4
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial.双阿司匹林交联血红蛋白(DCLHb)治疗严重创伤性失血性休克:一项随机对照疗效试验。
JAMA. 1999 Nov 17;282(19):1857-64. doi: 10.1001/jama.282.19.1857.
5
Shock index and prediction of traumatic hemorrhagic shock 28-day mortality: data from the DCLHb resuscitation clinical trials.休克指数与创伤性失血性休克28天死亡率的预测:来自DCLHb复苏临床试验的数据。
West J Emerg Med. 2014 Nov;15(7):795-802. doi: 10.5811/westjem.2014.7.21304. Epub 2014 Sep 25.
6
A safety assessment of diaspirin cross-linked hemoglobin (DCLHb) in the treatment of hemorrhagic, hypovolemic shock.双阿司匹林交联血红蛋白(DCLHb)治疗出血性低血容量性休克的安全性评估。
Prehosp Disaster Med. 1999 Oct-Dec;14(4):251-64.
7
Resuscitation from severe hemorrhagic shock after traumatic brain injury using saline, shed blood, or a blood substitute.使用生理盐水、自体失血或血液替代品对创伤性脑损伤后严重失血性休克进行复苏。
Shock. 2002 Mar;17(3):234-44. doi: 10.1097/00024382-200203000-00013.
8
Fluid resuscitation from severe hemorrhagic shock using diaspirin cross-linked hemoglobin fails to improve pancreatic and renal perfusion.使用双阿司匹林交联血红蛋白对严重失血性休克进行液体复苏未能改善胰腺和肾脏灌注。
Acta Anaesthesiol Scand. 2004 Nov;48(10):1328-37. doi: 10.1111/j.1399-6576.2004.00475.x.
9
Diaspirin cross-linked hemoglobin fails to improve left ventricular diastolic function after fluid resuscitation from hemorrhagic shock.从失血性休克进行液体复苏后,双阿司匹林交联血红蛋白未能改善左心室舒张功能。
Eur Surg Res. 2001 Sep-Dec;33(5-6):318-26. doi: 10.1159/000049725.
10
Does increased prehospital replacement volume lead to a poor clinical course and an increased mortality? A matched-pair analysis of 1896 patients of the Trauma Registry of the German Society for Trauma Surgery who were managed by an emergency doctor at the accident site.院前替换容量增加是否会导致不良临床病程和死亡率增加?对德国创伤外科学会创伤登记处的 1896 名由事故现场急救医生处理的患者进行配对分析。
Injury. 2013 May;44(5):611-7. doi: 10.1016/j.injury.2012.02.004. Epub 2012 Feb 28.

引用本文的文献

1
Artificial blood for therapeutic and laboratory usage: Where do we stand?用于治疗和实验室用途的人造血液:我们目前的进展如何?
Biomicrofluidics. 2024 Sep 25;18(5):051505. doi: 10.1063/5.0186931. eCollection 2024 Sep.
2
Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.基于血红蛋白的氧载体的毒性机制及其调控。
Shock. 2019 Oct;52(1S Suppl 1):41-49. doi: 10.1097/SHK.0000000000001044.
3
Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?基于血红蛋白的血液替代品与镰状细胞病的治疗:弊大于利?
Biomolecules. 2017 Jan 4;7(1):2. doi: 10.3390/biom7010002.
4
Prehospital volume therapy as an independent risk factor after trauma.创伤后院前容量治疗作为一个独立危险因素
Biomed Res Int. 2015;2015:354367. doi: 10.1155/2015/354367. Epub 2015 Apr 9.